Dyadic International has expanded its bio-industrial pipeline with a new proprietary enzyme program focused on advanced cellulose processing, building on the success of its EN3ZYME™ product. This initiative leverages Dyadic's Dapibus™ platform to streamline development and manufacturing, targeting applications like pulp biorefining and nanocellulose production. The move taps into a growing multi-billion-dollar industrial enzyme market driven by demand for cost-effective, eco-friendly alternatives to chemical processes. Dyadic plans to commercialize through product sales, partnerships, and licensing, aiming to diversify revenue and support long-term growth.
Bitcoin's recent price recovery is supported by significant institutional investment, particularly through regulated ETFs, signaling a shift toward long-term ownership. Despite some volatility and a U.S. legislative setback on crypto regulation, infl...
The First Trust High Yield Opportunities 2027 Term Fund (FTHY) is experiencing near-term volatility and weak distribution coverage, with its discount widening despite an approaching liquidation date. However, the fund's term structure may lead to a v...
Glassnode's Altcoin Cycle Signal rose to 86 in June, indicating altcoins outperform Bitcoin, mainly due to Bitcoin's 18% drop rather than strong altcoin demand. By early July, the signal confirmed genuine altcoin strength, but by September, despite a...
The Bitwise Solana Staking ETF (BSOL) attracted over $60 million in new investments in the last two days, raising its assets under management to an all-time high of more than $1.2 billion. This surge reflects growing investor confidence in Solana's p...
Zappin, a new Telegram-based trading bot, launched on Robinhood Chain on September 21, allowing users to swap tokens via Uniswap and receive 90% of their trading fees back in ETH for 30 days. This promotion aims to attract early users to Robinhood's ...
